QUAKER CHEMICAL CORP (KWR): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
QUAKER CHEMICAL CORP (KWR) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. kwr-20260630 0000081362 FALSE 0000081362 2026-06-30 2026-06-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 June 30, 2026 Date of Report (Date of earliest eve
How this was made
The 30-second read
Why it matters
The change updates the principal accounting officer role from Steven Dassing to CFO Coler effective July 22, 2026; the filing states the resignation is not due to disputes and includes no new compensatory arrangements.
Market read
This is a governance/accounting leadership update with no stated controversy; it is more relevant for monitoring than for immediate re-pricing.
What to watch
Watch for subsequent filings (e.g., amended controls disclosures, restatement language, or audit committee updates) around the July 22 effective date, which are not present here.
Background
The company filed an SEC Form 8-K (Item 5.02) reporting an officer resignation and the appointment of a new Principal Accounting Officer.
Ticker impact
Quaker Chemical disclosed Steven Dassing’s resignation as VP Corporate Controller and Principal Accounting Officer, effective July 22, 2026, with CFO Coler taking over.
Limited immediate price impact; any reaction likely muted unless investors read it as governance/accounting quality signal.
The filing is a routine officer change with no dispute, disagreement, or new compensatory terms; it mainly updates who holds the principal accounting officer role.
Market effects
Minimal; this is company-specific officer succession rather than an industry/regulatory development.
None indicated; US-listed issuer filing only.
None indicated; no cross-border deal, contract, or regulatory action described.
Counterpoint
Investors could still scrutinize the accounting-control transition for any hidden issues, even though the filing explicitly says no dispute or disagreement.
Key entities
- issuerQuaker Chemical Corporation
US-listed company filing the 8-K regarding officer departure and appointment of Principal Accounting Officer.
- officerSteven Dassing
Resigning VP, Corporate Controller, and Principal Accounting Officer effective July 22, 2026.
- officerMr. Coler
Executive Vice President and Chief Financial Officer who will serve as Principal Accounting Officer in addition to current role.

